Late Stage Investors & VC Firms in Netherlands

72 firms in this list, with a median first check of $1.1M. 16 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
SO Solid Ventures HDRWDBFS6 people	88🔒	Amsterdam	NL	Series B–Late Stage	$550K – $5.5M	+ Add to CRM
WA Waterman Ventures PRMKWV3 people	88🔒	Utrecht	NL	Seed–Late Stage	—	+ Add to CRM
DS dsm-firmenich Venturing AKADIBSH9 people	88🔒	Maastricht	NL	Pre-Seed–Late Stage	$108K – $5.4M	+ Add to CRM
SA Sanaga Ventures ACBW2 people	88🔒	Amsterdam	NL	Pre-Seed–Late Stage	—	+ Add to CRM
SC Schouten Investments MSAS2 people	88🔒	Amsterdam	NL	Series B–Late Stage	—	+ Add to CRM
GR Greentrail Capital SB1 person	88🔒	Amsterdam		Series A–Late Stage	—	+ Add to CRM
AA AAC Capital Partners	88🔒	—	NL	Growth–Late Stage	—	+ Add to CRM
AM Amerborgh	88🔒	Baarn	NL	Late Stage	—	+ Add to CRM
EG Egeria EP1 person	88🔒	Amsterdam, Noord Holla	NL	Growth–Late Stage	—	+ Add to CRM
GE General Atlantic AGACACAF83 people · Leads rounds	88🔒	New York	US	Series B–Late Stage	$10M – $1B	+ Add to CRM
RI Rivean Capital AKBCDGGF60 people	88🔒	Brussels	BE	Growth–Late Stage	—	+ Add to CRM
AT Atomico NZBBJBLC35 people · Follows rounds	88🔒	London	GB	Seed–Late Stage	—	+ Add to CRM
ME Metaplanet JTRMGDSB6 people · Follows rounds	88🔒	Tallinn	EE	Seed–Late Stage	$500K – $10M	+ Add to CRM
KO Korys DCGAHSBD40 people	88🔒	Halle	BE	Series A–Late Stage	$5.4M	+ Add to CRM
EQ EQT Life Sciences PFADAPBJ42 people · Leads rounds	88🔒	Luxembourg	LU	Seed–Late Stage	$11M – $66M	+ Add to CRM
B2 b2venture AGCSDFFS36 people · Follows rounds	88🔒	Berlin	DE	Pre-Seed–Late Stage	$270K – $5.4M	+ Add to CRM
KL Klar Partners CJFBAMAK32 people	88🔒	London	GB	Growth–Late Stage	$27.5M – $275M	+ Add to CRM
SM SmartFin BLJIHHSD23 people	88🔒	Brussels	BE	Seed–Late Stage	$1.1M – $55M	+ Add to CRM
EU European Circular Bioeconomy Fund DSMBMNIL23 people	88🔒	Bonn	DE	Series A–Late Stage	$5.5M – $16.5M	+ Add to CRM
EU Eurazeo LGLMMTNW12 people	88🔒	Paris	FR	Series A–Late Stage	—	+ Add to CRM
M8 M80 Partners JDVFCJFB19 people · Leads rounds	88🔒	Brussels	BE	Growth–Late Stage	$11M – $66M	+ Add to CRM
BL Blue Horizon Corporation Follows rounds	88🔒	Zurich	CH	Pre-Seed–Late Stage	—	+ Add to CRM
MO Motive Partners RNPLAL3 people · Leads rounds	88🔒	New York	US	Pre-Seed–Late Stage	$1M – $10M	+ Add to CRM
DE Debiopharm Innovation Fund MCTMCTDS18 people · Leads rounds	88🔒	Lausanne	CH	Pre-Seed–Late Stage	$1M – $5M	+ Add to CRM

Solid Ventures

AmsterdamSeries B–Late Stage$550K – $5.5M

HDRWDBFS6 people

Waterman Ventures

UtrechtSeed–Late Stage

PRMKWV3 people

dsm-firmenich Venturing

MaastrichtPre-Seed–Late Stage$108K – $5.4M

AKADIBSH9 people

Sanaga Ventures

AmsterdamPre-Seed–Late Stage

ACBW2 people

Schouten Investments

AmsterdamSeries B–Late Stage

MSAS2 people

Greentrail Capital

AmsterdamSeries A–Late Stage

SB1 person

AAC Capital Partners

Growth–Late Stage

Amerborgh

BaarnLate Stage

Egeria

Amsterdam, Noord HollaGrowth–Late Stage

EP1 person

General Atlantic

New YorkSeries B–Late Stage$10M – $1B

AGACACAF83 people

Rivean Capital

BrusselsGrowth–Late Stage

AKBCDGGF60 people

Atomico

LondonSeed–Late Stage

NZBBJBLC35 people

Metaplanet

TallinnSeed–Late Stage$500K – $10M

JTRMGDSB6 people

Korys

HalleSeries A–Late Stage$5.4M

DCGAHSBD40 people

EQT Life Sciences

LuxembourgSeed–Late Stage$11M – $66M

PFADAPBJ42 people

b2venture

BerlinPre-Seed–Late Stage$270K – $5.4M

AGCSDFFS36 people

Klar Partners

LondonGrowth–Late Stage$27.5M – $275M

CJFBAMAK32 people

SmartFin

BrusselsSeed–Late Stage$1.1M – $55M

BLJIHHSD23 people

European Circular Bioeconomy Fund

BonnSeries A–Late Stage$5.5M – $16.5M

DSMBMNIL23 people

Eurazeo

ParisSeries A–Late Stage

LGLMMTNW12 people

M80 Partners

BrusselsGrowth–Late Stage$11M – $66M

JDVFCJFB19 people

Blue Horizon Corporation

ZurichPre-Seed–Late Stage

Motive Partners

New YorkPre-Seed–Late Stage$1M – $10M

RNPLAL3 people

Debiopharm Innovation Fund

LausannePre-Seed–Late Stage$1M – $5M

MCTMCTDS18 people

Data sourced from public filings and firms' own websites — see our methodology.